A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 7, 2009, Pages 781-791

  Dikman, A ^b   Sanyal, S ^b   Von Althann, C ^b   Whitson, M ^b   Desai, J ^b   Bodian, C ^b   Brooks, A ^c   Bamji, N ^b   Cohen, L ^b   Miller, K ^b   Aisenberg, J ^a,b  

^a Mount Sinai Medical Center ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CLOPIDOGREL; NAPROXEN; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DUODENUM BIOPSY; EXPERIMENTAL MODEL; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; HEALING IMPAIRMENT; HUMAN; HUMAN EXPERIMENT; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STOMACH BIOPSY; ULCER HEALING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; NAPROXEN; PEPTIC ULCER; PILOT PROJECTS; PYRAZOLES; SULFONAMIDES; TICLOPIDINE; YOUNG ADULT;

EID: 61849111082     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.03928.x     Document Type: Article

References (44)

1. Gonzalez MEL, Rodrigue GLA. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. AP&T 2008 28 : 629 37.
2. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002 346 : 2033 8.
3. Ng FH, Wong Y, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcers. AP&T 2003 18 : 443 9.
4. Lanas A, Garcia-Rodriguez LA, Arroya MT, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007 102 : 507 15.
5. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007 50 : e1 157.
6. Chan FK, Ching JL, Hung LCT, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2007 352 : 238 44.
7. Wallace JL. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: current knowledge and future research. Am J Med 2001 110 : 19S 23S.
8. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005 2116 : S24 33.
9. Tarnawski AS, Jones MK. Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med 2003 81 : 627 36.
10. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005 352 : 238 44.
11. Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications 1. Clin Gastroenterol Hepatol 2006 3565 : 7.
12. Ma L, del Soldato P, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proc Natl Acad Sci U S A 2002 99 : 13243 7.
13. Brzozowski T, Konturek PC, Konturek SJ, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 2001 53 : 343 53.
14. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000 119 : 706 14.
15. Dorta G, Nicolet M, Vouillamoz D, et al. Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Aliment Pharmacol Ther 1996 10 : 563 9.
16. Stadler P, Armstrong D, Margalith D, et al. Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers. Dig Dis Sci 1991 5 : 594 600.
17. Laine L, Maller ES, Yu C, Quan H, Simon T. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004 127 : 395 402.
18. Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998 104 : 43S 51S.
19. Lanas A, Hirschowitz BI. Toxicity of NSAIDs in the stomach and duodenum. Eur J Gastroenterol Hepatol 1999 11 : 375 81.
20. Berenguer B, Alarcon de la Lastra C, Moreno FJ, Martin MJ. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors. Eur J Pharmacol 2002 442 : 124 35.
21. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of COX-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997 112 : 387 97.
22. Levi S, Walport MJ, Hodgon HJF, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associate with gastric ulcer healing. Lancet 1990 336 : 840 3.
23. Sanchez-Fidalgo S, Mart¡n-Lacave I, Illanes M, Motilva V. Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor. Eur J Pharmacol 2004 505 : 187 94.
24. Schmassmann A, Zoidl G, Peskar BM, et al. Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice 1. Am J Physiol Gastrointest Liver Physiol 2006 290 : G747 56.
25. Hull MA, Thomson JL, Hawkey CJ. Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells. Gut 1999 45 : 529 36.
26. Chan FKL, Wong VWS, Suen BY, et al. Effect of celecoxib on the healing of complicated gastric ulcers: a prospective, double-blinded, randomized trial. Gastro 2005 128 (Suppl 2 A24 5.
27. Chan FK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004 19 : 1051 61.
28. Fork FT, Lafolie P, Toth E, Lindgarde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in health volunteers. Scand J Gastroenterol 2000 35 : 464 9.
29. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996 348 : 1329 39.
30. Cryer B. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies. N Engl J Med 2005 352 : 287 9.
31. Tarnawski A, Hollander D, Krause WJ, Dabros W, Stachura J, Gergely H. "Healed" experimental gastric ulcers remain histologically and ultrastructurally abnormal. J Clin Gastroenterol 1990 12 : S139 47.
32. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 2001 98 : 6470 5.
33. Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor 4. Br J Pharmacol 2006 148 : 274 8.
34. Sibilia V, Pagani F, Lattuada N, et al. Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat. Pharmacol Res 2007 55 : 418 25.
35. Perini R, Wallace JL, Ma L. Roles of platelets and proteinase-activated receptors in gastric ulcer healing. Dig Dis Sci 2005 50 : S12 5.
36. Deng X, Szabo S, Khomenko T, Jadus MR, Yoshida M. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 2004 311 : 982 8.
37. Jones MK, Kawanaka H, Baatar D, et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 2001 121 : 1040 7.
38. Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest 2001 119 : 39S 63S.
39. Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005 353 : 2373 83.
40. Mosler P, Mergener K, Denzer U, Kiesslich R, Galle PR, Kanzler S. Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy - a nation-wide survey in Germany. Z Gastroenterologie 2008 46 : 712 24.
41. Lee S, Tang SJ, Rockey DC, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc 2008 67 : 1076 81.
42. Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 2001 53 : 620 7.
43. Kimchi NA, Broide E, Scapa E, Birkenfeld S. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations. Digestion 2007 75 : 36 45.
44. Zuckerman MJ, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005 61 : 189 94.